Literature DB >> 32302489

Respiratory and Cardiovascular Outcomes in Survivors of Extremely Preterm Birth at 19 Years.

John R Hurst1, Joanne Beckmann2, Yanyan Ni2, Charlotte E Bolton3,4, Carmel M McEniery5, John R Cockcroft6, Neil Marlow2.   

Abstract

Rationale: Growth and development during adolescence may modify the respiratory and vascular differences seen among extremely preterm (EP) individuals in childhood and early adolescence.
Objectives: To assess the trajectory of respiratory and cardiovascular outcomes during transition to adulthood in a national longitudinal cohort study of births before 26 weeks of gestation in the United Kingdom and Ireland.
Methods: A total of 129 EP participants and 65 control subjects attended for a center-based evaluation at 19 years of age. Standardized measures of spirometry, hemodynamics, functional capacity, and markers of inflammation were obtained from EP subjects with and without neonatal bronchopulmonary dysplasia and term-born control subjects at 19 years of age and compared with previous assessments.Measurements and Main
Results: Compared with the control group, the EP group was significantly impaired on all spirometric parameters (mean FEV1 z-score, -1.08 SD [95% confidence interval, -1.40 to -0.77]) and had lower fractional exhaled nitric oxide concentrations (13.9 vs. 24.4 ppb; P < 0.001) despite a higher proportion with bronchodilator reversibility (27% vs. 6%). The EP group had significantly impaired exercise capacity. All respiratory parameters were worse after neonatal bronchopulmonary dysplasia, and respiratory function differences were similar at 11 and 19 years. The augmentation index was 6% higher in the EP group and associated with increased total peripheral resistance (difference in means, 96.4 [95% confidence interval, 26.6-166.2] dyne/s/cm-5) and elevation in central, but not peripheral, blood pressure. Central systolic and diastolic blood pressures increased more quickly during adolescence in the EP group than in the control group.Conclusions: Clinicians should address both cardiovascular and respiratory risks in adult survivors of extremely preterm birth.

Entities:  

Keywords:  adult outcomes; cardiovascular function; extreme prematurity; lung function

Mesh:

Substances:

Year:  2020        PMID: 32302489      PMCID: PMC7397792          DOI: 10.1164/rccm.202001-0016OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

Review 1.  General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review.

Authors:  Aisling Gough; Dale Spence; Mark Linden; Henry L Halliday; Lorcan P A McGarvey
Journal:  Chest       Date:  2011-11-23       Impact factor: 9.410

2.  Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance.

Authors:  Manjith Narayanan; John Owers-Bradley; Caroline S Beardsmore; Marius Mada; Iain Ball; Ruslan Garipov; Kuldeep S Panesar; Claudia E Kuehni; Ben D Spycher; Sian E Williams; Michael Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

3.  Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT).

Authors:  Carmel M McEniery; Ian R Hall; Ahmad Qasem; Ian B Wilkinson; John R Cockcroft
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

4.  Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease.

Authors:  Julio A Chirinos; Juan P Zambrano; Simon Chakko; Anila Veerani; Alan Schob; Howard J Willens; Guido Perez; Armando J Mendez
Journal:  Hypertension       Date:  2005-04-18       Impact factor: 10.190

Review 5.  Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis.

Authors:  Xiaoli Chen; Youfa Wang
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

6.  Airway obstruction in young adults born extremely preterm or extremely low birth weight in the postsurfactant era.

Authors:  Lex William Doyle; Louis Irving; Anjali Haikerwal; Katherine Lee; Sarath Ranganathan; Jeanie Cheong
Journal:  Thorax       Date:  2019-09-26       Impact factor: 9.139

7.  Respiratory health in pre-school and school age children following extremely preterm birth.

Authors:  E M Hennessy; M A Bracewell; N Wood; D Wolke; Kate Costeloe; A Gibson; N Marlow
Journal:  Arch Dis Child       Date:  2008-06-18       Impact factor: 3.791

8.  Cardiovascular consequences of extreme prematurity: the EPICure study.

Authors:  Carmel M McEniery; Charlotte E Bolton; Joseph Fawke; Enid Hennessy; Janet Stocks; Ian B Wilkinson; John R Cockcroft; Neil Marlow
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

9.  Airway microbiome in adult survivors of extremely preterm birth: the EPICure study.

Authors:  Sylvia A D Rofael; Timothy D McHugh; Rachael Troughton; Joanne Beckmann; David Spratt; Neil Marlow; John R Hurst
Journal:  Eur Respir J       Date:  2019-01-10       Impact factor: 16.671

10.  The EPICure study: association between hemodynamics and lung function at 11 years after extremely preterm birth.

Authors:  Charlotte E Bolton; Janet Stocks; Enid Hennessy; John R Cockcroft; Joseph Fawke; Sooky Lum; Carmel M McEniery; Ian B Wilkinson; Neil Marlow
Journal:  J Pediatr       Date:  2012-05-09       Impact factor: 4.406

View more
  20 in total

1.  Longitudinal changes in lung function in very prematurely born young people receiving high-frequency oscillation or conventional ventilation from birth.

Authors:  Alessandra Bisquera; Christopher Harris; Alan Lunt; Sanja Zivanovic; Neil Marlow; Sandy Calvert; Anne Greenough; Janet L Peacock
Journal:  Pediatr Pulmonol       Date:  2022-04-18

Review 2.  Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm.

Authors:  Joseph W Duke; Adam J Lewandowski; Steven H Abman; Andrew T Lovering
Journal:  J Physiol       Date:  2022-01-12       Impact factor: 6.228

3.  What is BPD today and in the next 50 years?

Authors:  Richard J Martin; Alan H Jobe; Eduardo Bancalari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-13       Impact factor: 6.011

4.  Endothelial to mesenchymal transition during neonatal hyperoxia-induced pulmonary hypertension.

Authors:  Jiannan Gong; Zihang Feng; Abigail L Peterson; Jennifer F Carr; Alexander Vang; Julie Braza; Gaurav Choudhary; Phyllis A Dennery; Hongwei Yao
Journal:  J Pathol       Date:  2020-10-06       Impact factor: 7.996

Review 5.  Modern pulmonary imaging of bronchopulmonary dysplasia.

Authors:  Nara S Higano; J Lauren Ruoss; Jason C Woods
Journal:  J Perinatol       Date:  2021-02-05       Impact factor: 2.521

6.  Update in Pediatrics 2020.

Authors:  Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

Review 7.  Predicting Long-Term Respiratory Outcomes in Premature Infants: Is It Time to Move beyond Bronchopulmonary Dysplasia?

Authors:  Deepak Jain; Alexander Feldman; Subhasri Sangam
Journal:  Children (Basel)       Date:  2020-12-10

8.  Respiratory distress syndrome and bronchopulmonary dysplasia after fetal growth restriction: Lessons from a natural experiment in identical twins.

Authors:  Sophie G Groene; Jip A Spekman; Arjan B Te Pas; Bastiaan T Heijmans; Monique C Haak; Jeanine M M van Klink; Arno A W Roest; Enrico Lopriore
Journal:  EClinicalMedicine       Date:  2021-01-29

Review 9.  Respiratory and cardiopulmonary limitations to aerobic exercise capacity in adults born preterm.

Authors:  Joseph W Duke; Andrew T Lovering
Journal:  J Appl Physiol (1985)       Date:  2020-08-13

10.  Impact of the Vulnerable Preterm Heart and Circulation on Adult Cardiovascular Disease Risk.

Authors:  Adam J Lewandowski; Philip T Levy; Melissa L Bates; Patrick J McNamara; Anne Monique Nuyt; Kara N Goss
Journal:  Hypertension       Date:  2020-08-17       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.